Citigroup »

Krystal Biotech shares owned by Citigroup

Quarter-by-quarter ownership of Krystal Biotech (KRYS) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Krystal Biotech

Tip: Access up to 7 years of quarterly data

All positions including Krystal Biotech held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Krystal Biotech by Citigroup

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.5M 37k 124.10
2023-09-30 $7.0M 61k 116.00
2023-03-31 $5.4M 67k 80.06
2022-12-31 $2.3M 29k 79.22
2022-09-30 $3.5M 50k 69.69
2021-12-31 $2.4M 35k 69.94
2021-03-31 $3.1M 39k 78.65
2020-12-31 $1.2M 22k 56.82
2020-09-30 $79k 1.7k 45.45
2020-06-30 $1.6M 34k 45.45
2020-03-31 $2.6M 60k 43.31
2019-12-31 $3.4M 61k 55.40
2019-09-30 $485k 14k 35.04
2019-06-30 $99k 2.5k 40.46
2019-03-31 $728k 22k 32.93
2018-12-31 $214k 10k 20.77